East Ventures on Instagram: "Nusantics raised a new round of Series A funding led by East Ventures. The startup also welcomed @triawanmunaf as a commissioner. The fresh funding is a fruit of @nusantics’ strong growth and its swift response to the disruptions brought on by the COVID-19 pandemic. After successfully repurposing its capability to develop two generations of COVID-19 PCR test kits, Nusantics is currently developing their third-generation COVID-19 PCR test kit that can detect SARS-CoV-2 in a salivary sample. Nusantics will use this fresh funding to further enhance its RnD capability so the company can continue its innovation in the field of microbiome analysis and medical diagnostic kits. Triawan Munaf expressed his enthusiasm on being a part of the "significant journey" with Nusantics. “Indonesia's rich biodiversity makes it the ‘world's pharmacy’. We must protect the future of our children and the generations to come by preserving this biodiverse wealth and preventing exploitation for other interests that do not benefit us as a nation. This underlines the urgency to support the growth of startups like Nusantics,” said Venture Advisor at East Ventures Triawan Munaf. Read more: http://bit.ly/nusantics-A"

eastventures

View this post on Instagram

A post shared by East Ventures (@eastventures)